Cell Systems News — COVID-19
Research on the COVID-19 virus is uncovering the virus may, in some cases, be attacking endothelial cells and potentially causing systemic inflammation. This paper titled "Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke" showcases research that utilized our human primary brain microvascular endothelial cells (ACBRI 376). Cell Systems offers a wide variety of human primary endothelial cells that are isolated without the use of antibodies. Our cells are more biologically relevant and offer outstanding consistency and quality for your research programs. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256621/pdf/main.pdf #endothelialcells #covid19 #coronavirus #cellsystems
The COVID-19 pandemic has upended much of the global economy. While most individual's lives have been disrupted, we are still seeing tremendous progress in the scientific community to research this virus and ultimately create a vaccine. As a provider of primary cells to researchers around the world, Cell Systems is ready to ship cells, media and reagents to enable valuable research to continue. Though the insights surrounding this virus are still in the early stage, there has been some interesting papers surrounding COVID-19 and vascular biology -- particularly endothelial cells, including this one in The Lancet. Cell Systems has a large...